| RS2511483095 |
RNF213
|
Health Risk |
Likely pathogenic |
See cases, See cases |
| RS2511483243 |
RNF213
|
Health Risk |
Likely pathogenic |
Moyamoya disease 2, Moyamoya disease 2 |
| RS2511483611 |
LOXHD1
|
Health Risk |
Likely pathogenic |
— |
| RS2511487515 |
EPG5
|
Health Risk |
Pathogenic |
Vici syndrome, Vici syndrome |
| RS2511488169 |
RAX
|
Health Risk |
Likely pathogenic |
Isolated microphthalmia 3, Isolated microphthalmia 3 |
| RS2511488658 |
RAX
|
Health Risk |
Pathogenic |
Isolated microphthalmia 3, Isolated microphthalmia 3 |
| RS2511490484 |
RNF213
|
Health Risk |
Pathogenic |
— |
| RS2511491044 |
KIF26A
|
Health Risk |
Likely pathogenic |
Cortical dysplasia, complex |
| RS2511491127 |
EPG5
|
Health Risk |
Pathogenic |
Vici syndrome, Vici syndrome |
| RS2511491486 |
EPG5
|
Health Risk |
Pathogenic |
Vici syndrome, Vici syndrome |
| RS2511492071 |
KIF26A
|
Health Risk |
Pathogenic |
Cortical dysplasia, complex |
| RS2511493694 |
KIF26A
|
Health Risk |
Likely pathogenic |
Cortical dysplasia, complex |
| RS2511494250 |
LOXHD1
|
Health Risk |
Likely pathogenic |
— |
| RS2511494549 |
LOXHD1
|
Health Risk |
Likely pathogenic |
Autosomal recessive nonsyndromic hearing loss 77, Autosomal recessive nonsyndromic hearing loss 77 |
| RS2511495207 |
LOXHD1
|
Health Risk |
Likely pathogenic |
Autosomal recessive nonsyndromic hearing loss 77, Autosomal recessive nonsyndromic hearing loss 77 |
| RS2511495976 |
LOXHD1
|
Health Risk |
Pathogenic |
— |
| RS2511496807 |
TCF4
|
Health Risk |
Pathogenic/Likely pathogenic |
Pitt-Hopkins syndrome, Pitt-Hopkins syndrome |
| RS2511496811 |
LOXHD1
|
Health Risk |
Likely pathogenic |
Autosomal recessive nonsyndromic hearing loss 77, Autosomal recessive nonsyndromic hearing loss 77 |
| RS2511498290 |
TCF4
|
Health Risk |
Likely pathogenic |
TCF4-related disorder, TCF4-related disorder |
| RS2511499126 |
TCF4
|
Health Risk |
Pathogenic |
Pitt-Hopkins syndrome, Pitt-Hopkins syndrome |
| RS2511499685 |
TCF4
|
Health Risk |
Pathogenic |
Developmental disorder, Developmental disorder |
| RS2511499903 |
TCF4
|
Health Risk |
Conflicting classifications of pathogenicity |
Pitt-Hopkins syndrome, Corneal dystrophy |
| RS2511501679 |
LAMA3
|
Health Risk |
Pathogenic |
— |
| RS2511505737 |
MALT1
|
Health Risk |
Pathogenic |
Combined immunodeficiency due to MALT1 deficiency, Combined immunodeficiency due to MALT1 deficiency |
| RS2511506957 |
LAMA3
|
Health Risk |
Pathogenic |
— |
| RS2511512432 |
FECH
|
Health Risk |
Pathogenic |
— |
| RS2511512805 |
LOXHD1
|
Health Risk |
Pathogenic |
— |
| RS2511512891 |
LOXHD1
|
Health Risk |
Pathogenic |
— |
| RS2511513107 |
EPG5
|
Health Risk |
Likely pathogenic |
Vici syndrome, Vici syndrome |
| RS2511513261 |
EPG5
|
Health Risk |
Pathogenic |
Vici syndrome, Vici syndrome |
| RS2511513874 |
LOXHD1
|
Health Risk |
Likely pathogenic |
Autosomal recessive nonsyndromic hearing loss 77, Autosomal recessive nonsyndromic hearing loss 77 |
| RS2511517010 |
LMAN1
|
Health Risk |
Likely pathogenic |
— |
| RS2511517143 |
FECH
|
Health Risk |
Pathogenic |
— |
| RS2511517215 |
FECH
|
Health Risk |
Pathogenic |
Autosomal erythropoietic protoporphyria, Autosomal erythropoietic protoporphyria |
| RS2511517302 |
FECH
|
Health Risk |
Pathogenic |
— |
| RS2511517502 |
FECH
|
Health Risk |
Pathogenic |
— |
| RS2511517542 |
FECH
|
Health Risk |
Pathogenic |
— |
| RS2511517710 |
FECH
|
Health Risk |
Likely pathogenic |
— |
| RS2511528486 |
FECH
|
Health Risk |
Likely pathogenic |
— |
| RS2511528538 |
FECH
|
Health Risk |
Likely pathogenic |
Protoporphyria, erythropoietic |
| RS2511528572 |
FECH
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2511528650 |
FECH
|
Health Risk |
Pathogenic |
— |
| RS2511539097 |
FECH
|
Health Risk |
Likely pathogenic |
FECH-related disorder, FECH-related disorder |
| RS2511542522 |
RNF213
|
Health Risk |
Likely pathogenic |
Moyamoya disease 2, Moyamoya disease 2 |
| RS2511543235 |
LAMA3
|
Health Risk |
Likely pathogenic |
Junctional epidermolysis bullosa, Junctional epidermolysis bullosa |
| RS2511546700 |
LAMA3
|
Health Risk |
Likely pathogenic |
Junctional epidermolysis bullosa, non-Herlitz type |
| RS2511547533 |
CCBE1
|
Health Risk |
Pathogenic |
— |
| RS2511547897 |
EPG5
|
Health Risk |
Pathogenic |
Vici syndrome, Vici syndrome |
| RS2511547936 |
EPG5
|
Health Risk |
Pathogenic |
Vici syndrome, Vici syndrome |
| RS2511547994 |
LAMA3
|
Health Risk |
Pathogenic/Likely pathogenic |
Epidermolysis bullosa, junctional 2B |
| RS2511548203 |
EPG5
|
Health Risk |
Likely pathogenic |
Vici syndrome, Vici syndrome |
| RS2511556441 |
MALT1
|
Health Risk |
Pathogenic |
Combined immunodeficiency due to MALT1 deficiency, Combined immunodeficiency due to MALT1 deficiency |
| RS2511556556 |
MALT1
|
Health Risk |
Pathogenic |
Combined immunodeficiency due to MALT1 deficiency, Combined immunodeficiency due to MALT1 deficiency |
| RS2511560242 |
DNAH17
|
Health Risk |
Likely pathogenic |
Spermatogenic failure 39, Spermatogenic failure 39 |
| RS2511564239 |
MALT1
|
Health Risk |
Pathogenic |
— |
| RS2511566983 |
TNFRSF11A
|
Health Risk |
Likely pathogenic |
Autosomal recessive osteopetrosis 7, Autosomal recessive osteopetrosis 7 |
| RS2511568251 |
LOXHD1
|
Health Risk |
Pathogenic |
— |
| RS2511568423 |
LOXHD1
|
Health Risk |
Likely pathogenic |
Autosomal recessive nonsyndromic hearing loss 77, Autosomal recessive nonsyndromic hearing loss 77 |
| RS2511568533 |
EPG5
|
Health Risk |
Pathogenic |
Vici syndrome, Vici syndrome |
| RS2511569016 |
LOXHD1
|
Health Risk |
Pathogenic |
— |
| RS2511570088 |
LOXHD1
|
Health Risk |
Pathogenic |
— |
| RS2511570527 |
LOXHD1
|
Health Risk |
Pathogenic |
— |
| RS2511570627 |
LOXHD1
|
Health Risk |
Likely pathogenic |
— |
| RS2511572182 |
RNF213
|
Health Risk |
Likely pathogenic |
Moyamoya disease 2, Moyamoya disease 2 |
| RS2511575230 |
NARS1
|
Health Risk |
Likely pathogenic |
— |
| RS2511575841 |
TNFRSF11A
|
Health Risk |
Pathogenic |
— |
| RS2511575856 |
EPG5
|
Health Risk |
Pathogenic |
Vici syndrome, Vici syndrome |
| RS2511576695 |
NARS1
|
Health Risk |
Pathogenic |
NARS1-related disorder, NARS1-related disorder |
| RS2511577420 |
EPG5
|
Health Risk |
Pathogenic |
Vici syndrome, Vici syndrome |
| RS2511577837 |
EPG5
|
Health Risk |
Pathogenic |
Vici syndrome, Vici syndrome |
| RS2511580498 |
LAMA3
|
Health Risk |
Pathogenic |
— |
| RS2511581197 |
LAMA3
|
Health Risk |
Likely pathogenic |
Junctional epidermolysis bullosa, Junctional epidermolysis bullosa |
| RS2511581925 |
TCF4
|
Health Risk |
Pathogenic |
Pitt-Hopkins syndrome, Pitt-Hopkins syndrome |
| RS2511585414 |
TCF4
|
Health Risk |
Likely pathogenic |
Pitt-Hopkins syndrome, Pitt-Hopkins syndrome |
| RS2511591727 |
TNFRSF11A
|
Health Risk |
Pathogenic |
— |
| RS2511592639 |
EPG5
|
Health Risk |
Pathogenic |
Vici syndrome, Vici syndrome |
| RS2511593052 |
EPG5
|
Health Risk |
Likely pathogenic |
— |
| RS2511593094 |
TNFRSF11A
|
Health Risk |
Pathogenic |
— |
| RS2511593392 |
EPG5
|
Health Risk |
Pathogenic |
Vici syndrome, Vici syndrome |
| RS2511593479 |
EPG5
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2511598176 |
LOXHD1
|
Health Risk |
Likely pathogenic |
Autosomal recessive nonsyndromic hearing loss 77, Autosomal recessive nonsyndromic hearing loss 77 |
| RS2511598355 |
LOXHD1
|
Health Risk |
Pathogenic |
— |
| RS2511598572 |
LOXHD1
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive nonsyndromic hearing loss 77, Autosomal recessive nonsyndromic hearing loss 77 |
| RS2511599836 |
LOXHD1
|
Health Risk |
Pathogenic |
— |
| RS2511609422 |
EPG5
|
Health Risk |
Pathogenic |
Vici syndrome, Vici syndrome |
| RS2511609488 |
LAMA3
|
Health Risk |
Pathogenic |
— |
| RS2511610263 |
ATP8B1
|
Health Risk |
Pathogenic |
— |
| RS2511612853 |
LOXHD1
|
Health Risk |
Likely pathogenic |
Autosomal recessive nonsyndromic hearing loss 77, Autosomal recessive nonsyndromic hearing loss 77 |
| RS2511612946 |
CCBE1
|
Health Risk |
Pathogenic |
— |
| RS2511613077 |
LOXHD1
|
Health Risk |
Pathogenic |
— |
| RS2511614912 |
LOXHD1
|
Health Risk |
Likely pathogenic |
Autosomal recessive nonsyndromic hearing loss 77, Autosomal recessive nonsyndromic hearing loss 77 |
| RS2511616619 |
ATP8B1
|
Health Risk |
Pathogenic |
— |
| RS2511618910 |
ATP8B1
|
Health Risk |
Pathogenic |
— |
| RS2511619782 |
ATP8B1
|
Health Risk |
Pathogenic |
— |
| RS2511619878 |
ATP8B1
|
Health Risk |
Pathogenic |
— |
| RS2511625072 |
EPG5
|
Health Risk |
Pathogenic |
Vici syndrome, Vici syndrome |
| RS2511625410 |
ATP8B1
|
Health Risk |
Pathogenic |
— |
| RS2511625419 |
ATP8B1
|
Health Risk |
Pathogenic |
— |
| RS2511625549 |
EPG5
|
Health Risk |
Pathogenic |
Vici syndrome, Vici syndrome |
| RS2511627573 |
GREB1L
|
Health Risk |
Likely pathogenic |
GREB1L-related disorder, GREB1L-related disorder |